Eric A. Klein

57.4k total citations · 9 hit papers
733 papers, 29.8k citations indexed

About

Eric A. Klein is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Eric A. Klein has authored 733 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 491 papers in Pulmonary and Respiratory Medicine, 148 papers in Surgery and 125 papers in Cancer Research. Recurrent topics in Eric A. Klein's work include Prostate Cancer Treatment and Research (375 papers), Prostate Cancer Diagnosis and Treatment (358 papers) and Bladder and Urothelial Cancer Treatments (77 papers). Eric A. Klein is often cited by papers focused on Prostate Cancer Treatment and Research (375 papers), Prostate Cancer Diagnosis and Treatment (358 papers) and Bladder and Urothelial Cancer Treatments (77 papers). Eric A. Klein collaborates with scholars based in United States, Canada and Germany. Eric A. Klein's co-authors include Patrick A. Kupelian, Andrew J. Stephenson, C.A. Reddy, Michael W. Kattan, Cristina Magi‐Galluzzi, Alwyn M. Reuther, Craig D. Zippe, Jay P. Ciezki, Peter T. Scardino and James A. Eastham and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eric A. Klein

701 papers receiving 29.1k citations

Hit Papers

Quality of Life and Satis... 2005 2026 2012 2019 2008 2015 2007 2005 2021 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
    2008 1.7k citations Eric A. Klein, David P. Wood et al. profile →
  2. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
    2015 945 citations Cristina Magi‐Galluzzi, Eric A. Klein et al. profile →
  3. Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
    2007 633 citations Andrew J. Stephenson, Eric A. Klein et al. profile →
  4. Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy
    2005 522 citations Andrew J. Stephenson, Eric A. Klein et al. profile →
  5. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
    2021 520 citations Eric A. Klein, Kathryn N. Kurtzman et al. profile →
  6. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
    2011 468 citations Alan W. Partin, David P. Wood et al. The Journal of Urology profile →
  7. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
    2014 447 citations Eric A. Klein, Cristina Magi‐Galluzzi et al. profile →
  8. Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
    2013 289 citations Ian M. Thompson, Eric A. Klein et al. The Journal of Urology profile →
  9. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
    2023 168 citations Eric T. Fung, Eric A. Klein et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eric A. Klein 19.7k 6.0k 5.0k 4.8k 4.7k 733 29.8k
Ian M. Thompson 20.6k 1.0× 6.1k 1.0× 7.1k 1.4× 6.2k 1.3× 5.3k 1.1× 897 37.6k
Alan W. Partin 31.0k 1.6× 6.5k 1.1× 7.6k 1.5× 4.9k 1.0× 5.4k 1.2× 657 40.3k
Hendrik Van Poppel 19.0k 1.0× 6.5k 1.1× 6.7k 1.3× 3.3k 0.7× 3.6k 0.8× 567 24.9k
John T. Wei 13.3k 0.7× 4.9k 0.8× 4.7k 0.9× 3.4k 0.7× 3.3k 0.7× 378 23.7k
Peter R. Carroll 30.7k 1.6× 10.2k 1.7× 7.8k 1.6× 7.5k 1.6× 5.6k 1.2× 880 46.0k
William J. Catàlona 20.9k 1.1× 8.0k 1.3× 4.8k 1.0× 4.4k 0.9× 2.7k 0.6× 547 31.2k
Judd W. Moul 14.6k 0.7× 3.9k 0.6× 3.9k 0.8× 3.9k 0.8× 3.2k 0.7× 526 20.5k
Martin G. Sanda 10.2k 0.5× 2.4k 0.4× 4.7k 0.9× 3.9k 0.8× 2.0k 0.4× 268 17.6k
Peter T. Scardino 40.7k 2.1× 10.1k 1.7× 8.2k 1.6× 7.1k 1.5× 6.5k 1.4× 738 52.0k
Markus Graefen 20.2k 1.0× 6.7k 1.1× 3.1k 0.6× 3.8k 0.8× 2.7k 0.6× 927 26.6k

Countries citing papers authored by Eric A. Klein

Since Specialization
Citations

This map shows the geographic impact of Eric A. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Klein more than expected).

Fields of papers citing papers by Eric A. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Klein. The network helps show where Eric A. Klein may publish in the future.

Co-authorship network of co-authors of Eric A. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Klein. A scholar is included among the top collaborators of Eric A. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Klein. Eric A. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell, Rebecca A., Andrew Wood, Ao Zhang, et al.. (2024). PD26-02 THE PROLONGED LOW RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER DIAGNOSIS IN MEN WITH AN ELEVATED PSA BUT LOW IsoPSA. The Journal of Urology. 211(5S). 1 indexed citations
2.
Ornstein, Moshe Chaim, Shilpa Gupta, Jesse K. McKenney, et al.. (2024). A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC). Urologic Oncology Seminars and Original Investigations. 42. S31–S31.
3.
Stovsky, Mark, Alan W. Partin, Yair Lotan, et al.. (2023). IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study. Urology. 175. 132–136. 2 indexed citations
4.
Chen, Xiaoji, Dong Zhao, Earl Hubbell, et al.. (2021). Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA. Clinical Cancer Research. 27(15). 4221–4229. 79 indexed citations
5.
Thomas, Lewis J., Cristina Magi‐Galluzzi, Jianbo Li, et al.. (2021). Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 40(3). 104.e1–104.e7. 6 indexed citations
6.
Tang, Wei, Tiffany A. Wallace, Ming Yi, et al.. (2018). IFNL4 -ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer. Clinical Cancer Research. 24(21). 5471–5481. 38 indexed citations
7.
Dai, Charles S., Yoon-Mi Chung, Evan Kovac, et al.. (2017). Direct Metabolic Interrogation of Dihydrotestosterone Biosynthesis from Adrenal Precursors in Primary Prostatectomy Tissues. Clinical Cancer Research. 23(20). 6351–6362. 38 indexed citations
8.
You, Sungyong, Beatrice S. Knudsen, Nicholas Erho, et al.. (2016). Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Research. 76(17). 4948–4958. 132 indexed citations
9.
Chan, June M., Amy K. Darke, Kathryn L. Penney, et al.. (2016). Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1050–1058. 47 indexed citations
10.
Zhao, Shuang G., Joseph R. Evans, Vishal Kothari, et al.. (2015). The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer. Clinical Cancer Research. 22(7). 1777–1786. 43 indexed citations
11.
Chatterjee, Payel, Gaurav S. Choudhary, Warren D.W. Heston, et al.. (2015). The TMPRSS2–ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition. Molecular Cancer Therapeutics. 14(8). 1896–1906. 30 indexed citations
12.
Albanes, Demetrius, Cathee Till, Eric A. Klein, et al.. (2014). Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prevention Research. 7(9). 886–895. 49 indexed citations
13.
Lee, Byron, Peggy Robinet, Jonathan D. Smith, et al.. (2012). Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1. Cancer Research. 73(3). 1211–1218. 124 indexed citations
14.
Marshall, James R., Catherine M. Tangen, Wael Sakr, et al.. (2011). Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917. Cancer Prevention Research. 4(11). 1761–1769. 83 indexed citations
15.
Platz, Elizabeth A., Cathee Till, Phyllis J. Goodman, et al.. (2009). Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 18(11). 2807–2813. 133 indexed citations
16.
Dong, Beihua, Sanggu Kim, Seunghee Hong, et al.. (2007). An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proceedings of the National Academy of Sciences. 104(5). 1655–1660. 161 indexed citations
17.
Klein, Eric A.. (2004). Management of Prostate Cancer. Humana Press eBooks. 3 indexed citations
18.
Klein, Eric A.. (2002). Opportunities for Prevention of Prostate Cancer: Genetics, Chemoprevention, and Dietary Intervention. Europe PMC (PubMed Central). 6 indexed citations
19.
Klein, Eric A.. (2000). Management of Prostate Cancer. Humana Press eBooks. 3 indexed citations
20.
Pontes, J. Edson, James E. Montie, Eric A. Klein, & Robert P. Huben. (1993). Salvage surgery for radiation failure in prostate cancer. Cancer. 71(S3). 976–980. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian M. Thompson Breakdown of academic impact, for papers by Alan W. Partin Breakdown of academic impact, for papers by Hendrik Van Poppel Breakdown of academic impact, for papers by John T. Wei Breakdown of academic impact, for papers by Peter R. Carroll Breakdown of academic impact, for papers by William J. Catàlona Breakdown of academic impact, for papers by Judd W. Moul Breakdown of academic impact, for papers by Martin G. Sanda Breakdown of academic impact, for papers by Peter T. Scardino Breakdown of academic impact, for papers by Markus Graefen
Rankless by CCL
2026